Related Experiment Video

Updated: Aug 23, 2025

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

216

MCM2 in human cancer: functions, mechanisms, and clinical significance

Yaoqi Sun1, Zhongping Cheng2, Shupeng Liu3,4

  • 1Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.

Molecular Medicine (Cambridge, Mass.)
|October 28, 2022
PubMed
Abstract

Insights

Minichromosome maintenance 2 (MCM2) dysfunction drives cancer by impairing DNA replication and cell proliferation. Targeting MCM2 shows promise for cancer treatment and immunotherapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Aberrant DNA replication is a primary driver of genomic instability, leading to cancer initiation and progression.
  • Minichromosome maintenance 2 (MCM2), a key component of the eukaryotic helicase, is crucial for DNA replication.
  • MCM2 dysfunction is implicated in the development and advancement of various cancers by disrupting DNA replication and cell proliferation.

Purpose of the Study:

  • To investigate the role of MCM2 in cancer development and progression.
  • To evaluate MCM2 as a potential biomarker for cancer diagnosis and prognosis.
  • To explore the therapeutic potential of targeting MCM2 in cancer treatment and immunotherapy.

Main Methods:

  • Analysis of MCM2 expression levels in various cancer types.
  • Correlation of MCM2 expression with clinicopathological features and patient outcomes.
  • Assessment of the anti-tumor effects of MCM2 inhibition.
  • Investigation of DNA replication stress in MCM2-deficient cells and its impact on anti-tumor immunity.

Main Results:

  • MCM2 overexpression is frequently observed in multiple cancers.
  • MCM2 dysfunction correlates with tumor progression and poor patient prognosis.
  • Inhibition of MCM2 demonstrates anti-tumor effects.
  • MCM2 deficiency leads to DNA replication stress, potentially enhancing anti-tumor immunity.

Conclusions:

  • MCM2 is a critical regulator of DNA replication and a significant factor in tumorigenesis.
  • Altered MCM2 expression serves as a potential biomarker for cancer diagnosis, prognosis, and predicting chemotherapy response.
  • Targeting MCM2 presents a promising therapeutic strategy for cancer treatment, potentially improving the efficacy of tumor immunotherapy due to induced replication stress.
Keywords:
BiomarkerDNA replicationImmunotherapyMCM2Tumor

More Related Videos

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

10.4K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K